Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT07339059 · RECRUITING

Trial details

NCT number: NCT07339059
Sponsor: Bindu R Potugari
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer ( SCLC )Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Start date: 2026-05-14
Primary completion: 2029-02-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.